OCUL – ocular therapeutix, inc. (US:NASDAQ)
Stock Stats
News
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $20.00 price target on the stock.
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Ocular Therapeutix™ Announces Plans to Accelerate NDA Submission Timeline for AXPAXLI™ in Wet AMD
Ocular Therapeutix (OCUL) Valuation After Accelerated AXPAXLI NDA Plan in Wet AMD [Yahoo! Finance]
Form 8-K OCULAR THERAPEUTIX, INC For: Dec 18
Form SCHEDULE 13G OCULAR THERAPEUTIX, INC Filed by: SUMMER ROAD LLC
Form 8-K OCULAR THERAPEUTIX, INC For: Dec 05
Form 4 OCULAR THERAPEUTIX, INC For: Nov 24 Filed by: Nayak Sanjay
Form 4 OCULAR THERAPEUTIX, INC For: Nov 24 Filed by: Dugel Pravin
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.